Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM1 | Q13255 | 2/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9142496 | 1.00 | GRM1 (0.50) | GRM1FFAR3NSD2PKML3MBTL1 | |
| Hydrochloric Acid SCHEMBL8368069 | 0.96 | GRM1 (0.48) | GRM1FFAR3NSD2PKML3MBTL1 | |
| Hydrochloric Acid SCHEMBL5480359 | 0.96 | GRM1 (0.48) | GRM1FFAR3NSD2PKML3MBTL1 | |
| SCHEMBL18634863 | 0.87 | GRM1 (0.42) | GRM1FFAR3 | |
| SCHEMBL5607861 | 0.87 | GRM1 (0.42) | GRM1FFAR3 | |
| SCHEMBL478303 | 0.85 | GRM1 (0.40) | GRM1FFAR3 | |
| SCHEMBL16933182 | 0.85 | GRM1 (0.40) | GRM1FFAR3 | |
| SCHEMBL5607460 | 0.84 | GRM1 (0.41) | GRM1 | |
| SCHEMBL5556132 | 0.84 | PKM (0.52) | GRM1NSD2PKM | |
| SCHEMBL5082256 | 0.84 | GRM1 (0.41) | GRM1PKML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505197-A | Low-temperature-cured high-toughness polyester resin and preparation method and application thereof | 擎天材料科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119439618-A | Negative photosensitive resin composition, preparation method thereof and hardening film | 深圳市道尔顿电子材料股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-20250011524-A1 | BRANCHED ACRYLATE FUNCTIONAL OLIGOMERS | ARKEMA FRANCE (FR) | 2025-01-09 | — | — | US | claimed |
| CN-118596664-A | High-performance sealing gasket for large-size pipeline and preparation method thereof | 慈溪埃弗龙密封件有限公司 | 2024-09-06 | — | — | CN | claimed |
| EP-4408903-A1 | BRANCHED ACRYLATE FUNCTIONAL OLIGOMERS | ARKEMA FRANCE (FR) | 2024-08-07 | — | — | EP | claimed |
| CN-118304773-A | Preparation method of high-flux polyamide nanofiltration membrane based on twisted small molecules | 天津大学 | 2024-07-09 | — | — | CN | claimed |
| CN-116355229-B | Application of metal-organic framework material in separation of tetramethylsilane and isopentane | 苏州大学 | 2024-06-21 | — | — | CN | claimed |
| CN-116059969-B | Copper-based metal organic framework material and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-118019774-A | Branched acrylate functional oligomers | 阿科玛法国公司 | 2024-05-10 | — | — | CN | claimed |
| CN-114887601-B | For C 2 H 2 /C 2 H 4 MOF material with efficient separation performance and preparation method and application thereof | 金宏气体股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20070141511-A1 | Cyclic compound, photoresist composition and method of forming a photoresist pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-06-21 | — | — | US | claimed |
| US-20070026078-A1 | Pharmaceutical co-crystal compositions | TRANSFORM PHARMACEUTICALS, INC. (US) | 2007-02-01 | — | — | US | claimed |
| EP-1631260-A2 | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN | Transform Pharmaceuticals, Inc. (US) | 2006-03-08 | — | — | EP | claimed |
| EP-1608339-A1 | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN | Transform Pharmaceuticals, Inc. (US) | 2005-12-28 | — | — | EP | claimed |
| WO-2004078161-A1 | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPTINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN | TRANSFORM PHARMACEUTICALS, INC. (US) | 2004-09-16 | — | — | WO | claimed |
| WO-2004078163-A2 | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN | TRANSFORM PHARMACEUTICALS, INC. (US) | 2004-09-16 | — | — | WO | claimed |
| US-20030224006-A1 | Multiple-component solid phases containing at least one active pharmaceutical ingredient | UNIVERSITY OF SOUTH FLORIDA | 2003-12-04 | — | — | US | claimed |
| EP-0790253-B1 | Novel crystalline metal-organic microporous materials | NALCO CHEMICAL CO (US) | 2002-02-06 | — | — | EP | claimed |
| EP-0790253-A2 | Novel crystalline metal-organic microporous materials | NALCO CHEMICAL COMPANY (US) | 1997-08-20 | — | — | EP | claimed |
| US-5648508-A | MIXING METAL IONS WITH ORGANIC LIGANDS AND TEMPLATING AGENTS; FOR PURIFICATION OF LIQUIDS AND GASES | NALCO CHEMICAL COMPANY (US) | 1997-07-15 | — | — | US | claimed |